Results 21 to 30 of about 3,279 (166)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)

open access: yesНаучно-практическая ревматология, 2013
Objective: to estimate quality of life changes in patients with rheumatoid arthritis (RA) while adding tocilizumab (TCZ) to therapy with disease-modifying antirheumatic drugs (DMARDs) and to study the efficiency and safety of the therapy in RA patients ...
E Yu Panasyuk   +6 more
doaj   +1 more source

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis

open access: yesНаучно-практическая ревматология, 2012
Objective: to evaluate the clinical efficiency of tocilizumab (TCZ) versus rituximab (RTM) therapy using DAS 28, SDAI, and CDAI scores and to estimate remission rates using DAS 28 and the remission criteria proposed by the European League Against ...
Anastasia Sergeyevna Avdeyeva   +4 more
doaj   +1 more source

Prevalencia de ansiedad y factores correlacionados en pacientes atendidos en clínica integral de odontología: Un estudio transversal [PDF]

open access: yesRevista Científica Universidad Odontológica Dominicana
La ansiedad asociada con la atención odontológica es una preocupación común para muchas personas, manifestándose como una profunda inseguridad vinculada a las visitas y tratamientos dentales.
Luis Chauca Bajaña   +3 more
doaj   +1 more source

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS

open access: yesНаучно-практическая ревматология, 2012
Objective — to evaluate the impact of tocilizumab (TCZ) therapy on progression of joint destruction and rheumatoid arthritis (RA) inflammatory activity in 48 weeks after initiation of treatment. Material and methods.
Anastasia Sergeevna Avdeeva   +4 more
doaj   +1 more source

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)

open access: yesНаучно-практическая ревматология, 2014
Objective. To evaluate the effectiveness and tolerance of Etanercept (ETN) therapy in patients with rheumatoid arthritis (RA).Material and Methods. 188 adult patients with severe and moderate RA (average DAS28 score of 6.26±0.89) subcutaneously received ...
Anna Olegovna Pchelintseva   +12 more
doaj   +1 more source

Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression

open access: yesFrontiers in Medicine, 2021
Objective: To compare the capacity of various disease activity indices to evaluate changes in function, IL-6 levels, and radiographic progression in early and established rheumatoid arthritis (RA).Methods: Secondary data analysis of a clinical trial ...
Sebastián C. Rodriguez-García   +7 more
doaj   +1 more source

A Study of Correlation of Disease Severity with Antibody Titers in Rheumatoid Arthritis [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2019
Introduction: Rheumatoid Arthritis (RA) is one of the most frequent autoimmune diseases in the world which affects about 1% of people. Anti-Cyclic Citrullinated Peptides (Anti-CCP) is shown to be more specific than rheumatoid factor in the diagnosis of ...
Praveen Singh Madan   +4 more
doaj   +1 more source

Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis

open access: yesRheumatology and Therapy, 2023
Introduction One target of rheumatoid arthritis (RA) treatment is to achieve early sustained remission; over the long term, patients in sustained remission have less structural joint damage and physical disability.
Paul Emery   +14 more
doaj   +1 more source

Chinese registry of rheumatoid arthritis: IV. Correlation and consistency of rheumatoid arthritis disease activity indices in China

open access: yesChinese Medical Journal, 2021
. Background:. Disease activity indices (DAIs) including disease activity score 28 (DAS28), simplified disease activity index (SDAI), and clinical disease activity index (CDAI) have been widely used in clinical practice and research studies of rheumatoid
Xing Song   +7 more
doaj   +1 more source

Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis

open access: yesScientific Reports, 2023
HLA-DRB1 shared epitope risk alleles are the strongest genetic risk factors for rheumatoid arthritis (RA) and potential biomarkers for treatment response to biological disease-modifying antirheumatic drugs (bDMARDs).
Mariko Inoue   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy